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Text
Both humans and animals have used much energy when they move, 
work and continue activities.1 This energy is from the tricarboxylic 
acid (TCA) cycle which is well-known for years.2 It is also called as 
citric acid cycle (CAC) or Krebs cycle.3 It can produce much energy 
by the oxidation of acetyl-CoA derived from carbohydrates, fats, and 
proteins.4 Among them, carbohydrates axis seemed to be the main 
route for energy production in usual basic and clinical education 
and biochemistry in the medical school. However, there is a possible 
perspective that glucose had not made a central role.
Human beings in ancient times had showed evolutionary changes 
of metabolic programs.1 There were two situations for human 
nutritional circumstances. One was fasting which was common 
about 4-7million years. Due to food deprivation, elevated ketone 
bodies had main energy-producing system. Another was overeating 
which has been found in recent decades. Due to food abundance, 
people have gradually taken much refined cereals of carbohydrates.5 
Consequently, insulin resistance has been elevated, which has brought 
non-communicable diseases (NCDs) such as diabetes, obesity and 
metabolic syndrome.6 These changes caused social and medical 
problems in the world.5
  Regarding the concept of energy, there are some kinds of 
theories. There has been the energy balance theory for long, which 
was widely known. However, this theory alone has been not enough 
to explain various situations.7 From the nutritional balance, there are 
two principles which are conservation energy law and dissipation law. 
Some controversies are present in some situations as follows: i) low 
carbohydrate diet (LCD) brings more weight reduction than usual 
isocaloric diets,ii) there are metabolic advantages in comparison with 
energy laws, iii) protein can be changed to glucose by glucogenesis.7
Other theories or concepts are observed among them.The theory 
of Glycemic Index (GI) or Glycemic Load (GL) can change glucose 
variability to some extent.8 If a person restricts high GI foods and 
takes low GI foods more, his energy amount will be reduced.Another 
theory would be explained as “A calorie is not a calorie”. It means that 
various cases include different ratio of carbohydrate, lipid or protein, 
whereas they indicate the same total calories.9 Consequently, the 
metabolism of glucose differs in a variety of cases with macronutrient 
balance. 
Recently, a new idea was introduced that is the conventional calorie 
balance theory. It may be possible to explain the clinical phenomena 
where excessive insulin secretion will bring obesity.10 From this 
concept, a new theory was proposed as a carbohydrate-insulin model. 
The theory was advocated by Ebeling and Ludwig, who are on 
research association at the obesity prevention center of the Harvard 
University. Using this theory, the effective situation can be explained 
in the case of LCD and low GI meal in comparison with CR.11 When 
applying this theory into the research of Calorie Restriction (CR) for 
long term continuation, the result was not successful to explain the 
actual medical changes.12 
From mentioned above, such new concept will possibly contribute 
the development of clinical research for diabetes, obesity and 
metabolic syndrome. Such problems have become crucial medical 
problems across the world. By International Diabetes Federation 
(IDF), diabetes mellitus has been more prevalent,13 which has been 
increasing from 8.8% to 10.4%, in 2015 to 2040, respectively. Then, 
effective preventive method would be expected. In North American 
and European regions, Bernstein and Atkins had initiated LCD as 
a diet therapy.14,15 After LCD became rather popular, the clinical 
evidence was shown by Shai et al.16
 On the other hand, author and colleagues have started LCD since 
the 2000 in Japan.17 Successively, we have continued various clinical 
research concerning LCD and related matters.18 Continuation of 
LCD for type 2 diabetes mellitus brings weight reduction, improved 
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Abstract
Both humans and animals generate energy by tricarboxylic acid (TCA) cycle from 
carbohydrates, fats and proteins. Among them, carbohydrates axis seemed to be the main 
route for energy production so far. In the case of diabetes, however, the restraint of glucose 
metabolism would be beneficial by low carbohydrate diet (LCD) or newly-introduced oral 
hyperglycemic agent (OHA), Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i). Author 
and colleagues have developed LCD movement by Japan LCD promotion association 
(JLCDPA). Our lectures include useful and practical 3 LCD meals, which are petite-LCD, 
standard-LCD and super-LCD with carbohydrate content ratio as 40%, 26% and 12%, 
respectively. 
Keywords: tricarboxylic acid (TCA) cycle, low carbohydrate diet (LCD), sodium-
glucose cotransporter 2 inhibitors (SGLT2i), Japan LCD promotion association (JLCDPA), 
carbohydrate-insulin model
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HbA1c level and hyperketonemia, which are all beneficial to glucose 
variability.19,20 We have reported the physiological hyperketonemia 
in the axis of newborn, pregnant mother, placenta and fetus.21 
Furthermore, authors’ group have proposed the establishment of 
Japan LCD promotion association (JLCDPA) and developed various 
seminars, lectures, and social movement for LCD.
 Among the activity of JLCDPA, there are three recommended 
methods for continuing LCDs. They are petite-LCD, standard-LCD 
and super-LCD with the carbohydrate content ratio as 40%, 26% and 
12%, respectively.22 In these 3patterns, restricted carbohydrate amount 
per meal would be approximately <40g, <30g, <20g, respectively.20,22 
A person who plans to start LCD is advised to choose either type, 
according to the situation. People usually take 3meals a day. If a 
person skips taking carbohydrate food in 1, 2 or 3meals a day, it times 
a day, it is equivalent to petite-, standard-, or super-LCD. Medical 
staffs always consult with the subject to enough degree. 
One of the common educational handouts for seminar is shown 
in Figure 1. The important points were as follows: i) rice and fruits 
have much carbohydrates, ii) some dressings include moderate 
carbohydrate, iii) there are differences between fried chicken (0.1g) 
and deep-fried food (7g), iv) this meal has totally 118g of carbohydrate 
more than supposed. The subjects who want to continue LCD have to 
know the carbohydrate amount included in any kind of food.22 
Figure 1 Educational handout for LCD showing carbohydrate amount in a 
meal. 
Recently, there has been an impressive topic about oral 
hyperglycemic agent (OHA), which is the clinical introduction 
of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i).23 The 
characteristic point of the pharmaceutical function of SGLT2i would 
be increasing excretion of glucose into the urine.24 Clinical common 
mechanism of LCD and SGLT2i would be decreasing the metabolism 
of carbohydrate.25 Consequently, in the light of glucose variability, the 
presence of glucose in T2DM would be risky for various aspects, and 
its reduction would be beneficial for the prognosis.
In summary, some topics of diabetes were described including 
energy production, LCD, new theory of glucose and insulin, three 
patterns of LCD meals, SGLT2i. From clinical point of view, restraint 
of glucose would be beneficial for better diabetic control and less 
glucose metabolism in various situations. This article will hopefully 








1. Wang A, Luan HH, Medzhitov R. An evolutionary perspective on 
immunometabolism. Science. 2012;363(6423):eaar3932. 
2. Lowenstein JM. Methods in Enzymology. Volume 13: Citric Acid Cycle. 
Boston: Academic Press. 1969.
3. KrebsHA, Johnson WA. Metabolism of ketonic acids in animal tissues. 
The Biochemical Journal. 1937;31(4):645–60. 
4. Kay J, Weitzman PD. Krebs’ citric acid cycle: half a century and still 
turning. London: Biochemical Society. 1987. p. 25. 
5. Bando H. The Era of Reducing Sugary Food for Prevention on Lifestyle 
Related Diseases. J Clin Diabetol and Care. 2019;1(1):2019080001.
6. Mattson MP. An Evolutionary Perspective on Why Food Overconsumption 
Impairs Cognition. Trends in Cognitive. 2019. 
7. Feinman RD, Fine EJ. A calorie is a calorie. violates the second law of 
thermodynamics. Nutr J. 2004;28(3):9.
8. Evans CE, Greenwood DC, Threapleton DE, et al. Glycemic index, 
glycemic load, and blood pressure: a systematic review and meta–analysis 
of randomized controlled trials. The American Journal of Clinical 
Nutrition. 2017;105(5):1176–1190. 
9. Benton D, Young HA. Reducing Calorie Intake May Not Help You Lose 
Body Weight. Perspectives on Psychological Science. 2017;12(5):703–
714. 
10. Brotman DJ. Effects of counterregulatory hormones in a high–glycemic 
index diet. JAMA. 2002;288(6):695.
11. Ebbeling CB, Swain JF, Feldman HA, et al. Effects of dietary composition 
on energy expenditure during weight–loss maintenance. JAMA. 
2012;307(24):2627–2634. 
12. Ludwig DS, Ebbeling CB. The Carbohydrate–Insulin Model of Obesity. 
JAMA Internal Medicine. 2018;178(8):1098. 
13. Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes 
Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. 
Diabetes Res Clin Pract. 2017;128:40–50.
14. Atkins R. Dr. Atkins’ new diet revolution. Rev edn.Avon books, New York; 
1998.
15. Bernstein RK. Dr. Bernstein’s Diabetes solution: The Complete Guide to 
Achieving Normal Blood Sugars. Little, Brown US, New York. 2007.
16. Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a low–
carbohydrate, mediterranean, or low–fat diet. N Engl J Med. 
2008;359:229–241. 
17. Ebe K, Ebe Y, Yokota S, et al. Low Carbohydrate diet (LCD) treated for 
three cases as diabetic diet therapy. Kyoto Medical Association Journal. 
2004; 51:125–129.
18. Bando H, Ebe K, Muneta T, et al. Difference of Glucose variability 
between Low Carbohydrate Diet (LCD) and Calorie Restriction (CR). Asp 
Biomed Clin Case Rep. 2018;2(s1):4–15. 
Current topics of theory and practice for low carbohydrate diet (LCD) in diabetic patients  57
Copyright:
©2020 BANDO
Citation: BANDO H. Current topics of theory and practice for low carbohydrate diet (LCD) in diabetic patients. Endocrinol Metab Int J. 2020;8(2):55‒57. 
DOI: 10.15406/emij.2020.08.00279
19. Watanabe S, Hirakawa A, Utada I, et al. Ketone body production and 
excretion during wellness fasting. Diabetes Res Open J. 2017;3(1):1–8. 
20. Ebe K, Bando H, Yamamoto K, et al. Daily carbohydrate intake correlates 
with HbA1c in low carbohydrate diet (LCD). J Diabetol. 2018;1(1):4–9.
21. Muneta T, Kawaguchi E, Nagai Y, et al. Ketone body elevation in placenta, 
umbilical cord, newborn and mother in normal delivery. Glycative Stress 
Research. 2016;3(3):133–140. 
22. BandoH, Ebe K, Muneta T, et al. Clinical Effect of Low Carbohydrate Diet 
(LCD): Case Report. Diabetes Case Rep. 2017;2:124. 
23. Avogaro A, Fadini GP, Prato SD. Reinterpreting Cardiorenal Protection 
of Renal Sodium–Glucose Cotransporter 2 Inhibitors via Cellular Life 
History Programming. Diabetes Care. 2020;43(3):501–507.
24. Dorsey–Treviño EG, González–González JG, Alvarez–Villalobos N, et al. 
Sodium–glucose cotransporter 2 (SGLT–2) inhibitors and microvascular 
outcomes in patients with type 2 diabetes: systematic review and meta–
analysis. J Endocrinol Invest. 2020;43:289–304. 
25. Bando H. Clinical Influence of Sodium–Glucose Cotransporter 2 (SGLT2) 
Inhibitors for Cardiovascular and Renal Points of View. Diab Res Open 
Access. 2020;2(S1):9–13.
